Posts Tagged: $40 million
News
Nearly three years after a British firm abandoned a successful therapy for the life-threatening “bubble baby” disease, children will again be treated in a clinical trial backed with millions of dollars from the state of California. “It’s the best Christmas gift ever,” said the mother of an afflicted child, Andrea Fernandez.
News
With California’s statewide top-of-ticket races stacking up as weak-challenger romps, attention – and spending – turns to seven ballot measures, which taken together may well add up to the costliest state election ever. Experts say this could be the year that election-related spending tops $1 billion – a figure more in line with a presidential campaign.
News
The “bubble babies” saga and a California-financed cure for their life-threatening affliction has hit another snag, more than two years after a British company abandoned the effort. It is a story that involves more than $40 million from California’s stem cell agency, federal regulators, the University of California, the agonizingly slow pace of science and 20 children who have been denied care — not to mention a company called Orchard Therapeutics PLC.
News
Voters are facing the possibility of deciding among three fiercely competing ballot initiatives next year – all of them involving tens of millions of dollars and a revolution in California’s gambling industry. One of the three has already qualified for the November 2022 ballot. The remaining two must still gather signatures.
Opinion
OPINION: The California Water Commission is currently evaluating 11 proposals that are competing for $2.7 billion of the Prop. 1 funds set aside for storage projects. In December, the applicants made their cases directly to the commissioners in Sacramento, describing their purported “public benefits” to satisfy Proposition 1’s funding requirements.
News
The man often called the father of the California stem cell agency has all but said he is set to launch an effort to pump an additional $5 billion in state funding into the research effort, which is scheduled to run out of cash in about three years.